The game is afoot in the obesity space as GLP-1 rivals Eli Lilly and Novo Nordisk take their showdown to a new level. Lilly ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

After taking part in a landmark case against the manufacturers of the synthetic hormone DES, she represented many other ...

Plus, the National Academy of Sciences received $20 million, Agnes Scott College got $15 million, and three other ...

Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...

The first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

The first nonstop Aer Lingus flight from Dublin, Ireland landed Saturday night, but the long-term impact is just starting to take off.